***Please note this alert has been superseded by NatPSA/2024/011/DHSC, issued 21/10/2024***
Kay-Cee-L® (potassium chloride 5mmol/5ml) syrup
will be out of stock from late September 2024. The resupply date is to be
confirmed.
The supply disruption is caused by an amendment to the
manufacturing process, requiring re-formulation, and revalidation of the
product.
Sando-K® (potassium bicarbonate 400mg
and potassium chloride 600mg) effervescent tablets remain available and can
support a full increase in demand. One effervescent tablet contains 12mmol
potassium.
Unlicensed potassium chloride oral solutions manufactured
within the UK are available via Specials manufacturers.
Remaining supplies of Kay-Cee-L® syrup should be
prioritised for patients requiring doses of less than 12mmol of potassium and
where other preparations are not suitable (see Notes).
Care is needed to ensure selection of the most appropriate oral
potassium supplement and delivery of the correct dosage.
This National Patient Safety Alert provides further background, clinical information and actions for providers.